CEBP Grants Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Epidemiology Biomarkers & Prevention 16, 2448, November 1, 2007. doi: 10.1158/1055-9965.EPI-07-0480
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartzbaum, J. A.
Right arrow Articles by Feychting, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartzbaum, J. A.
Right arrow Articles by Feychting, M.

An International Case-Control Study of Interleukin-4R{alpha}, Interleukin-13, and Cyclooxygenase-2 Polymorphisms and Glioblastoma Risk

Judith A. Schwartzbaum1,2,3, Anders Ahlbom3, Stefan Lönn3, Beatrice Malmer4, Annette Wigertz3, Anssi Auvinen5, Anthony J. Brookes6, Helle Collatz Christensen7, Roger Henriksson4, Christoffer Johansen7, Tina Salminen5, Minouk J. Schoemaker8, Anthony J. Swerdlow8, Waldemar Debinski9 and Maria Feychting3

1 Division of Epidemiology, School of Public Health and 2 Comprehensive Cancer Center, Ohio State University, Columbus, Ohio; 3 Division of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 4 Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå, Sweden; 5 Departments of Epidemiology, Tampere School of Public Health, University of Tampere, Tampere, Finland; 6 Department of Genetics, University of Leicester, Leicester, United Kingdom; 7 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; and 8 Section of Epidemiology, Institute of Cancer Research, Surrey, United Kingdom; and 9 Wake Forest University, School of Medicine, Brain Tumor Center of Excellence, Wake Forest, North Carolina

Requests for reprints: Judith Schwartzbaum, Division of Epidemiology and Biometrics, School of Public Health, Ohio State University, Starling-Loving Hall, 320 West Tenth Avenue, Columbus, OH 43210. Phone: 614-268-1548; Fax: 614-293-3937. E-mail: schwartzbaum.1{at}osu.edu

Previous studies found that allergies are inversely related to risk of glioma. In an earlier publication, using data from a Swedish case-control study, Schwartzbaum et al. report an inverse relation between risk of glioblastoma and four single nucleotide polymorphisms (SNP) on two genes [interleukin (IL)-4R{alpha}, IL-13] that are associated with allergies. In addition, recent studies suggest that IL-4 and IL-13 induce cyclooxygenase-2 (COX-2) to resolve brain inflammation. To see whether previous Swedish results (110 cases, 430 controls) would be replicated, we estimated the association between glioblastoma and two IL-4R{alpha} (rs1805015, rs1801275) and two IL-13 (rs20541, rs1800925) SNPs and their haplotypes and one COX-2 SNP (–765GC) using additional English, Danish, and Finnish data (217 cases, 1,171 controls). Among general population controls, we evaluated associations between these haplotypes, the COX-2 SNP, and self-reported allergies. Our data did not support our original observations relating individual IL-4R{alpha}, IL-13, or COX-2 SNPs to glioblastoma risk. However, the T-G IL-4R{alpha} haplotype was associated with glioblastoma risk (odds ratio, 2.26; 95% confidence interval, 1.13-4.52) and there was a suggestion of an inverse relation between this haplotype and hayfever prevalence among controls (odds ratio, 0.38; 95% confidence interval, 0.14-1.03). The lack of support for a link between four IL-4R{alpha} and IL-13 SNPs and glioblastoma may reflect the absence of associations or may result from uncontrolled confounding by haplotypes related both to those that we examined and glioblastoma. Nonetheless, the association between the T-G IL-4R{alpha} haplotype and glioblastoma risk may indicate a role of immune factors in glioblastoma development. (Cancer Epidemiol Biomarkers Prev 2007;16(11):2448–54)




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Rajaraman, A. V. Brenner, M. A. Butler, S. S. Wang, R. M. Pfeiffer, A. M. Ruder, M. S. Linet, M. Yeager, Z. Wang, N. Orr, et al.
Common Variation in Genes Related to Innate Immunity and Risk of Adult Glioma
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1651 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. E. Scheurer, R. El-Zein, P. A. Thompson, K. D. Aldape, V. A. Levin, M. R. Gilbert, J. S. Weinberg, and M. L. Bondy
Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1277 - 1281.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.